Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study
Open Access
- 9 August 2022
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 22 (11), 1577-1586
- https://doi.org/10.1016/s1473-3099(22)00451-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectivenessThe Lancet, 2021
- Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) DatabaseInternational Journal of Epidemiology, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the roomThe Lancet Microbe, 2021
- Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infectionsArchives of Disease in Childhood, 2020
- A Test-Negative Design with Additional Population Controls Can Be Used to Rapidly Study Causes of the SARS-CoV-2 EpidemicEpidemiology, 2020
- Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national dataBMJ Open, 2020
- Welcome to the TidyverseThe Journal of Open Source Software, 2019
- The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) StatementPLoS Medicine, 2015
- Invited Commentary: Positivity in PracticeAmerican Journal of Epidemiology, 2010